DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/rhbhv9/investigation) has announced the addition of the "Investigation Report on China's Flurbiprofen Market, 2010-2019" report to their offering.
Non-steroidal anti-inflammatory drug (NSAID) has a totally different chemical structure from steroids which have a similar anti-inflammatory antirheumatic action. NSAID can also provide analgestic and antipyretic effects with fewer side effects compared with steroids. NSAID, be it nonprescription one or prescription one, has been the most widely used in the clinic. The market size of NSAID in China exceeded CNY 5 billion in 2014. Some varieties of NSAID have become OTC drugs in China since they are very common in the clinic.
By inhibiting the activity of cyclooxygenase and thereby the synthesis of prostaglandins, flurbiprofen is able to have pain-killing and fever-reducing effects. As flurbiprofen's molecular structure involves a fluorine atom, it has stronger effects even in small doses compared with similar drugs. Flurbiprofen ranks first in NSAIDs.
After entering China, flurbiprofen develops fast with annual sales value rising from less than CNY 2 million in 2005 to CNY 466 million in 2014 and CAGR during this period reaching up to 64.9%. Currently, flurbiprofen in the Chinese market mainly come from the following two companies: Beijing Tide Pharmaceutical Co., Ltd and MIKASA SEIYAKU CO.,LTD, the former having the larger market share of 99% for sales value in 2014.
The market size of flurbiprofen in China is expected to keep growing in the next few years in China.
Key Topics Covered:
1 Related Concepts of Flurbiprofen
2 Market Profile of Flurbiprofen in China
3 Survey on Sales Status of Flurbiprofen in China, 2010-2014
4 Survey on Market Share of Major Manufacturers of Flurbiprofen in China, 2010-2014
5 Survey on Sales Status of Dosage Forms of Flurbiprofen in China, 2010-2014
6 Reference Price of Flurbiprofen in Chinese Hospitals in 2014
7 Major Manufacturers of Flurbiprofen in Chinese Market, 2010-2014
8 Market Outlook of Flurbiprofen in China, 2015-2019
- Beijing Tide Pharmaceutical Co., Ltd
- MIKASA SEIYAKU CO., LTD
For more information visit http://www.researchandmarkets.com/research/rhbhv9/investigation